Andrew Cappetta joined SV in 2022 and became Vice President in 2025. He previously worked on corporate development at Thermo Fisher Scientific, focusing on healthcare and life science M&A.








At firms with a similar stage, sector and check size.





One email when Andrew's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAndrew Cappetta joined SV in 2022 and became Vice President in 2025. He previously worked on corporate development at Thermo Fisher Scientific, focusing on healthcare and life science M&A.
SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder SV Health Investors backed works best.
member of Corporate Development team at Thermo Fisher Scientific; Corporate Development team member at Thermo Fisher Scientific.
Last updated 2026-10-15. Is this you? Ask for a correction.